vs

Side-by-side financial comparison of Chatham Lodging Trust (CLDT) and Inogen Inc (INGN). Click either name above to swap in a different company.

Inogen Inc is the larger business by last-quarter revenue ($68.6M vs $67.7M, roughly 1.0× Chatham Lodging Trust). On growth, Inogen Inc posted the faster year-over-year revenue change (3.4% vs -9.8%). Over the past eight quarters, Inogen Inc's revenue compounded faster (4.2% CAGR vs -0.5%).

Chatham Lodging Trust is a publicly traded real estate investment trust that invests in, owns, and operates upscale extended-stay and select-service premium hotel properties primarily across high-demand urban and suburban markets in the United States. Its portfolio targets assets with strong occupancy rates and steady cash flow from business and leisure traveler segments.

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

CLDT vs INGN — Head-to-Head

Bigger by revenue
INGN
INGN
1.0× larger
INGN
$68.6M
$67.7M
CLDT
Growing faster (revenue YoY)
INGN
INGN
+13.2% gap
INGN
3.4%
-9.8%
CLDT
Faster 2-yr revenue CAGR
INGN
INGN
Annualised
INGN
4.2%
-0.5%
CLDT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLDT
CLDT
INGN
INGN
Revenue
$67.7M
$68.6M
Net Profit
$4.6M
Gross Margin
51.4%
Operating Margin
15.9%
-13.6%
Net Margin
6.8%
Revenue YoY
-9.8%
3.4%
Net Profit YoY
369.9%
EPS (diluted)
$0.05
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLDT
CLDT
INGN
INGN
Q4 25
$67.7M
$68.6M
Q3 25
$78.4M
$79.1M
Q2 25
$80.3M
$79.2M
Q1 25
$68.6M
$68.5M
Q4 24
$75.1M
$66.3M
Q3 24
$87.2M
$74.9M
Q2 24
$86.5M
$74.4M
Q1 24
$68.4M
$63.1M
Net Profit
CLDT
CLDT
INGN
INGN
Q4 25
$4.6M
Q3 25
$3.5M
$-5.3M
Q2 25
$5.4M
$-4.2M
Q1 25
$1.5M
$-6.2M
Q4 24
$-1.7M
Q3 24
$4.3M
$-6.0M
Q2 24
$6.8M
$-5.6M
Q1 24
$-5.2M
$-14.6M
Gross Margin
CLDT
CLDT
INGN
INGN
Q4 25
51.4%
Q3 25
52.2%
Q2 25
52.2%
Q1 25
53.1%
Q4 24
40.7%
54.7%
Q3 24
44.7%
55.2%
Q2 24
46.1%
57.4%
Q1 24
38.9%
54.5%
Operating Margin
CLDT
CLDT
INGN
INGN
Q4 25
15.9%
-13.6%
Q3 25
12.7%
-9.0%
Q2 25
14.8%
-7.7%
Q1 25
12.1%
-11.2%
Q4 24
7.5%
-17.2%
Q3 24
14.3%
-10.4%
Q2 24
16.3%
-9.5%
Q1 24
1.4%
-25.8%
Net Margin
CLDT
CLDT
INGN
INGN
Q4 25
6.8%
Q3 25
4.5%
-6.7%
Q2 25
6.7%
-5.2%
Q1 25
2.2%
-9.0%
Q4 24
-2.3%
Q3 24
4.9%
-8.0%
Q2 24
7.9%
-7.5%
Q1 24
-7.6%
-23.1%
EPS (diluted)
CLDT
CLDT
INGN
INGN
Q4 25
$0.05
$-0.26
Q3 25
$0.03
$-0.20
Q2 25
$0.07
$-0.15
Q1 25
$-0.01
$-0.25
Q4 24
$-0.08
$-0.41
Q3 24
$0.05
$-0.25
Q2 24
$0.10
$-0.24
Q1 24
$-0.15
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLDT
CLDT
INGN
INGN
Cash + ST InvestmentsLiquidity on hand
$24.4M
$103.7M
Total DebtLower is stronger
$338.9M
Stockholders' EquityBook value
$740.8M
$192.2M
Total Assets
$1.2B
$298.6M
Debt / EquityLower = less leverage
0.46×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLDT
CLDT
INGN
INGN
Q4 25
$24.4M
$103.7M
Q3 25
$13.2M
$106.5M
Q2 25
$17.2M
$103.7M
Q1 25
$18.6M
$118.9M
Q4 24
$20.2M
$113.8M
Q3 24
$19.3M
$105.7M
Q2 24
$10.6M
$97.9M
Q1 24
$72.3M
$107.4M
Total Debt
CLDT
CLDT
INGN
INGN
Q4 25
$338.9M
Q3 25
$338.8M
Q2 25
$351.2M
Q1 25
$381.1M
Q4 24
$406.9M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CLDT
CLDT
INGN
INGN
Q4 25
$740.8M
$192.2M
Q3 25
$749.4M
$197.2M
Q2 25
$754.1M
$199.5M
Q1 25
$754.7M
$198.0M
Q4 24
$758.2M
$173.9M
Q3 24
$765.3M
$185.4M
Q2 24
$766.5M
$187.6M
Q1 24
$765.0M
$191.9M
Total Assets
CLDT
CLDT
INGN
INGN
Q4 25
$1.2B
$298.6M
Q3 25
$1.2B
$307.0M
Q2 25
$1.2B
$312.0M
Q1 25
$1.2B
$308.4M
Q4 24
$1.3B
$296.2M
Q3 24
$1.3B
$306.2M
Q2 24
$1.3B
$308.9M
Q1 24
$1.3B
$315.6M
Debt / Equity
CLDT
CLDT
INGN
INGN
Q4 25
0.46×
Q3 25
0.45×
Q2 25
0.47×
Q1 25
0.50×
Q4 24
0.54×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLDT
CLDT
INGN
INGN
Operating Cash FlowLast quarter
$64.1M
$-943.0K
Free Cash FlowOCF − Capex
$-1.9M
FCF MarginFCF / Revenue
-2.8%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
13.90×
TTM Free Cash FlowTrailing 4 quarters
$-13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLDT
CLDT
INGN
INGN
Q4 25
$64.1M
$-943.0K
Q3 25
$25.6M
$2.2M
Q2 25
$22.1M
$4.3M
Q1 25
$4.2M
$-16.8M
Q4 24
$73.8M
$-3.0M
Q3 24
$28.8M
$7.0M
Q2 24
$25.2M
$6.7M
Q1 24
$6.9M
$-4.7M
Free Cash Flow
CLDT
CLDT
INGN
INGN
Q4 25
$-1.9M
Q3 25
$1.6M
Q2 25
$3.7M
Q1 25
$-17.1M
Q4 24
$-3.3M
Q3 24
$5.3M
Q2 24
$6.6M
Q1 24
$-6.1M
FCF Margin
CLDT
CLDT
INGN
INGN
Q4 25
-2.8%
Q3 25
2.0%
Q2 25
4.6%
Q1 25
-24.9%
Q4 24
-5.0%
Q3 24
7.1%
Q2 24
8.9%
Q1 24
-9.6%
Capex Intensity
CLDT
CLDT
INGN
INGN
Q4 25
1.4%
Q3 25
0.7%
Q2 25
0.9%
Q1 25
0.4%
Q4 24
0.5%
Q3 24
2.2%
Q2 24
0.1%
Q1 24
2.1%
Cash Conversion
CLDT
CLDT
INGN
INGN
Q4 25
13.90×
Q3 25
7.24×
Q2 25
4.10×
Q1 25
2.73×
Q4 24
Q3 24
6.78×
Q2 24
3.68×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLDT
CLDT

Occupancy$61.5M91%
Hotel Other$4.2M6%
Food And Beverage$1.8M3%
Hotel$1.1M2%

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

Related Comparisons